L

Ligand Pharmaceuticals
D

LGND

119.350
USD
2.54
(2.17%)
Market Closed
Volume
4,442
EPS
5
Div Yield
-
P/E
48
Market Cap
2,255,162,768
OverviewSignalsIdeasNews
Related Instruments
    A
    ACAD
    -0.240
    (-1.41%)
    16.790 USD
    A
    AGIO
    -1.645
    (-2.97%)
    53.810 USD
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    B
    BLUE
    -0.04270
    (-11.74%)
    0.32090 USD
    I
    ICPT
    0
    (0%)
    0.000000 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    J
    JAZZ
    -2.620
    (-2.11%)
    121.660 USD
    N
    NBIX
    -5.465
    (-4.45%)
    117.410 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    450.72 USD
    More
News

Title: Ligand Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license andmilestone payments, and sale of its trademarked Captisol material.